期刊文献+

阿司匹林和塞来昔布对乳腺癌细胞MCF-7增殖的影响 被引量:5

Effect of aspirin and celecoxib on proliferation of breast cancer cell line MCF-7
下载PDF
导出
摘要 目的:观察阿司匹林和塞来昔布及二者分别联合阿那曲唑对乳腺癌细胞MCF-7增殖的影响,探讨并比较阿司匹林和塞来昔布的抗肿瘤作用。方法:MTT法检测不同浓度的阿司匹林(2.5、5.0和10.0mmol.L-1)和塞来昔布(30、60和120μmol.L-1)分别作用人乳腺癌细胞株MCF-7不同时间(24、48和72h)的细胞增殖抑制率,以不含药物的培养液作为阴性对照组,以阿霉素作为阳性对照组。MTT法检测不同浓度阿那曲唑(0.5和1.0mmol.L-)及其分别联合不同浓度阿司匹林(2.5、5.0和10.0mmol.L-1)和塞来昔布(30、60和120μmol.L-1)作用于MCF-7细胞48h的细胞增殖抑制率,以不含药物组为阴性对照组。结果:①阿司匹林各剂量组细胞增殖抑制率随药物浓度的增加、作用时间的延长而提高(P<0.01)。②塞来昔布各剂量组的细胞增殖抑制率随药物浓度的增加、作用时间的延长而升高(P<0.01)。③10mmol.L-1阿司匹林和120μmol.L-1塞来昔布单独作用72h抑制率分别达68.88%和87.00%;阳性对照组阿霉素2.0μmol.L-1作用72h抑制率达86.30%。④0.5μmol.L-1阿那曲唑与阿司匹林联合各剂量组的抑制率均明显高于0.5μmol.L-1阿那曲唑单药组(P<0.05),0.5μmol.L-1阿那曲唑联合10.0mmol.L-1阿司匹林对MCF-7的抑制率明显高于0.5μmol.L-1阿那曲唑联合2.5、5.0mmol.L-1阿司匹林(P<0.05)。0.5μmol.L-1阿那曲唑分别与60、120μmol.L-1塞来昔布联合组的抑制率明显高于0.5μmol.L-1阿那曲唑单药组及0.5μmol.L-1阿那曲唑与30μmol.L-1塞来昔布联合组的抑制率(P<0.05),0.5μmol.L-1阿那曲唑联合120μmol.L-1塞来昔布对MCF-7的抑制率明显高于0.5μmol.L-1阿那曲唑联合60μmol.L-1塞来昔布(P<0.05)。1.0μmol.L-1阿那曲唑分别联合10.0mol.L-1阿司匹林、60和120μmol.L-1塞来昔布各组的抑制率明显高于1.0μmol.L-1阿那曲唑单药组(P<0.05),1.0μmol.L-1阿那曲唑联合120μmol.L-1塞来昔布对MCF-7的抑制率明显高于1.0μmol.L-1阿那曲唑联合60μm Objective To discuss and compare the anti-tumor effects of aspirin and celecoxib on breast cancer cell MCF-7 through investigating the effects of aspirin , celecoxib, and combined with anastrozole respectively on the growth of human breast cancer cell MCF-7. Methods The human breast cancer cell MCF-7 were treated with 2.5 , 5.0 , and 10.0 mmol·L^-1 aspirin and 30 , 60 , and 120 μmol ·L^-1 celecoxib for 24, 48, and 72 h respectively, the MCF-7 without treatment with drug was used as negative control group, the MCF-7 treated by ADM was used as positive control group, the inhibitory effect was detected by MTT assay. Besides, the MCF-7 cells were treated by anastrozole (0.5 and 1.0 μmol ·L^-1), anastrozole (0.5 and 1.0 μmol·L^-1 ) combined with aspirin (2.5 , 5.0 , and 10.0 mmol·L^-1) or celecoxib (30, 60, and 120 μmol ·L^-1) for 48 h, respectively, the inhibitory rate was detected by MTT assay. Results ① The inhibitory rate of the MCF-7 cell line treated with aspirin was reduced compared with controls, which was in time-dependent and dose-dependent manner (P〈0. 01). ②The inhibitory rate of the MCF-7 cell line treated with celecoxib was reduced compared with controls, which was in time-dependent and dose-dependent manner (P〈0. 01).③The inhibitory rates of 10 mmol·L^-1 aspirin and 120 μmol·L^-1 celecoxib on MCF-7 were 68. 88% and 87.00% when treated for 72 h, the inhibitory rate of 2. 0 μmol·L^-1 ADM on MCF-7 was 86.30% when treated for 72 h. ④The inhibitory rate of 0.5μmol·L^-1 anastrozole combined with aspirin on MCF-7 was increased compared with that of anastrozole single (P〈0. 05). The inhibitory rate of 0. 5 μmol·L^-1 anastrozole combined with 10.0 mmol·L^-1 aspirin on MCF-7 was increased compared with that of 0. 5 μmol·L^-1 anastrozole combined with 2.5 mmol·L^-1 or 5.0 mmol·L^-1 aspirin (P〈 0.05). The inhibitory rates of 0.5 μmol·L^-1 anastrozole combined with 60 μmol·L^-1 or 120 μmol·L^-1 eeleeoxib on MCF-7 were increased compared wi
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2007年第5期901-904,共4页 Journal of Jilin University:Medicine Edition
基金 吴阶平医学基金资助课题(320 2730 0501)
关键词 非甾体抗炎药 阿司匹林 塞来昔布 阿那曲唑 乳腺肿瘤 人乳腺癌细胞 MCF-7 nonsteroidal antiinflammatory drugs aspirin eeleeoxib anastrozole breast neoplasms human breast cancer cell MCF-7
  • 相关文献

参考文献9

  • 1Soslow R,Dannenberg A,Rush D,et al.Cox-2 is expression in human pulmonary,colnic and mammary tumor[J].Cancer,2000,98(12):2637-2645. 被引量:1
  • 2雷俊华,王杨,程少会.环氧合酶-2在胃癌组织中的表达及与病理参数的关系[J].吉林大学学报(医学版),2006,32(3):476-479. 被引量:4
  • 3战淑珺,江泽飞,宋三泰.COX-2抑制剂与乳腺癌关系研究进展[J].癌症进展,2005,3(1):45-48. 被引量:5
  • 4Davies GLS.Cyclooxygenase-2 and chemoprevention of breast cancer[J].J Steroid Biochem Mol Biol,2003,86(3-5):495. 被引量:1
  • 5Donowitz M,Pauker SG.Evaluation for colon cancer in patients with occult fecal blood loss while taking aspirin:a Bayesian viewpoint[J].Med Decis Making,1982,2(2):147-160. 被引量:1
  • 6Lanza-Jacoby S,Miller S,Flynn J,et a1.The cyclooxygenase-2 inhibitor,celecoxib,prevents the development of mammarytumors in Her-2/neu mice Cancer[J].Epidemiol Biomarkers JP,2003,12(12):1486-1491. 被引量:1
  • 7Abou-Issa HM,Alshafie GA,Seibe rt K,et a1.Doseresponse、efects of the COX-2 inhibitor,celecoxib,on the chemoprevention of mammary carcinogenesis[J].Anticancer Res,2001,21(5):3425-3432. 被引量:1
  • 8Nakatsugi S,Ohta T,Kawam ori T,et a1.Chemoprevention by nimesulide,a selective cycloxygenase-2 inhibitor,of 2-amino-1-methyl-6-phenylimidazol[4,5-b] pyridine(PhIP) -induced mammary gland carcinogenesis in rats[J].J Cancer Res,2000,91(9):886-892. 被引量:1
  • 9Arun B,Goss P.The role of COX-2 inhibition in breast cancer treatment and prevention[J].Semin Oncol,2004,31(2 Suppl7):22-29. 被引量:1

二级参考文献17

  • 1吴平,陈念平,黄冰,何惠娟,杨展.环氧化酶-2基因和蛋白在人胃癌组织中的表达及临床意义[J].中国肿瘤临床,2004,31(15):860-863. 被引量:6
  • 2Suo-LinFu Yun-LinWu Yong-PingZhang Min-MinQiao YingChen.Anti-cancer effects of COX-2 inhibitors and their correlation wit angiogenesis and invasion in gastric cancer[J].World Journal of Gastroenterology,2004,10(13):1971-1974. 被引量:22
  • 3[5]Davies GLS. Cyclooxygenase-2 and chemoprevention of breast cancer. J Steroid Biochem Mol Biol, 2003, 86 (3 ~ 5) :495 被引量:1
  • 4[6]Pesenti E, Masferrer JL, Salle E, et al. Effect of exemestane and celecoxib alone or in combination on DMBA - induced mammary carcinoma in rats. Breast Cancer Res Treat, 2001, 69 (3):288 被引量:1
  • 5[7]Arun B, Zhang H, Mirza NQ, et al. Growth inhibition of breast cancer cells by celecoxib. Breast Cancer Res Treat,2001, 69 (3) :234 被引量:1
  • 6[8]Paul EG, et al. Breast cancer prevention: Clinical trials strategies involving aromatase inhibitors. J Steroid Biochem Mol Biol,2003, 86 (3~5) :487 被引量:1
  • 7[9]Chow LW, Wong JL, Toi M. Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer: Preliminary report. J Steroid Biochem Mol Biol, 2003, 86 (3 ~ 5) :443 被引量:1
  • 8[10]Denoyelle C, Hong L, Vannier JP, et al. New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA - dependent and independent effects. Br J Cancer, 2003, 88 (10) :1631 被引量:1
  • 9[11]Lois M, Witters LM, Crispino J, et al. Effect of the combination of docetaxel, zoledronic acid, and a COX-2 inhibitor on the growth of human breast cancer cell lines. Am J Clin Oncol,2003, 26 (4) : S92 被引量:1
  • 10[12]Simeone AM, Li YJ, Broemeling LD, et al. Cyclooxygenase - 2 is essential for HER - 2/neu to suppress N- (4-hydroxyphenyl) retinamide apoptotic effects in breast cancer cells.Cancer Res, 2004, 64 (4) :1224 被引量:1

共引文献6

同被引文献66

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部